Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | The risk or severity of hyperglycemia can be increased when Fluocortolone caproate is combined with Ceritinib. |
| Corticorelin ovine triflutate | The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocortolone caproate. |
| Deferasirox | The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Fluocortolone caproate is combined with Deferasirox. |
| Amphotericin B | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Amphotericin B. |
| Isoetharine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Isoetharine. |
| Norepinephrine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Norepinephrine. |
| Phenylpropanolamine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Phenylpropanolamine. |
| Epinephrine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Epinephrine. |
| Orciprenaline | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Orciprenaline. |
| Dobutamine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Dobutamine. |
| Ritodrine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Ritodrine. |
| Terbutaline | The therapeutic efficacy of Terbutaline can be decreased when used in combination with Fluocortolone caproate. |
| Bitolterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Bitolterol. |
| Salmeterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Salmeterol. |
| Formoterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Formoterol. |
| Albuterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Salbutamol. |
| Isoprenaline | The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Fluocortolone caproate. |
| Arbutamine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Arbutamine. |
| Arformoterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Arformoterol. |
| Fenoterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Fenoterol. |
| Pirbuterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Pirbuterol. |
| Ephedra sinica root | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Ephedra sinica root. |
| Procaterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Procaterol. |
| Clenbuterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Clenbuterol. |
| Bambuterol | The therapeutic efficacy of Bambuterol can be decreased when used in combination with Fluocortolone caproate. |
| Celiprolol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Celiprolol. |
| Indacaterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Indacaterol. |
| Droxidopa | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Droxidopa. |
| Protokylol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Protokylol. |
| Hexoprenaline | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Hexoprenaline. |
| Olodaterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Olodaterol. |
| Vilanterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Vilanterol. |
| Doxofylline | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Doxofylline. |
| Racepinephrine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Racepinephrine. |
| Etafedrine | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Etafedrine. |
| PF-00610355 | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with PF-00610355. |
| Abediterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Abediterol. |
| Batefenterol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Batefenterol. |
| Levosalbutamol | The risk or severity of hypokalemia can be increased when Fluocortolone caproate is combined with Levosalbutamol. |
| Isoniazid | The serum concentration of Isoniazid can be decreased when it is combined with Fluocortolone caproate. |
| Mitotane | The serum concentration of Fluocortolone caproate can be decreased when it is combined with Mitotane. |
| Dicoumarol | Fluocortolone caproate may increase the anticoagulant activities of Dicoumarol. |
| Phenindione | Fluocortolone caproate may increase the anticoagulant activities of Phenindione. |
| Warfarin | Fluocortolone caproate may increase the anticoagulant activities of Warfarin. |
| Phenprocoumon | Fluocortolone caproate may increase the anticoagulant activities of Phenprocoumon. |
| Acenocoumarol | Fluocortolone caproate may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Fluocortolone caproate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Fluocortolone caproate may increase the anticoagulant activities of Coumarin. |
| (R)-warfarin | Fluocortolone caproate may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Fluocortolone caproate may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Fluindione | Fluocortolone caproate may increase the anticoagulant activities of Fluindione. |
| Clorindione | Fluocortolone caproate may increase the anticoagulant activities of Clorindione. |
| Diphenadione | Fluocortolone caproate may increase the anticoagulant activities of Diphenadione. |
| Tioclomarol | Fluocortolone caproate may increase the anticoagulant activities of Tioclomarol. |
| (S)-Warfarin | Fluocortolone caproate may increase the anticoagulant activities of (S)-Warfarin. |
| Nicorandil | The risk or severity of ulceration can be increased when Fluocortolone caproate is combined with Nicorandil. |
| Calcitriol | The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluocortolone caproate. |
| Calcifediol | The therapeutic efficacy of Calcifediol can be decreased when used in combination with Fluocortolone caproate. |
| Ergocalciferol | The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Fluocortolone caproate. |
| Cholecalciferol | The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Fluocortolone caproate. |
| Paricalcitol | The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Fluocortolone caproate. |
| Dihydrotachysterol | The therapeutic efficacy of Dihydrotachysterol can be decreased when used in combination with Fluocortolone caproate. |
| Alfacalcidol | The therapeutic efficacy of Alfacalcidol can be decreased when used in combination with Fluocortolone caproate. |
| Seocalcitol | The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Fluocortolone caproate. |
| Inecalcitol | The therapeutic efficacy of Inecalcitol can be decreased when used in combination with Fluocortolone caproate. |
| Becocalcidiol | The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Fluocortolone caproate. |
| Eldecalcitol | The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Fluocortolone caproate. |
| 1alpha,24S-Dihydroxyvitamin D2 | The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Fluocortolone caproate. |
| Elocalcitol | The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Fluocortolone caproate. |
| Maxacalcitol | The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Fluocortolone caproate. |
| Doxercalciferol | The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Fluocortolone caproate. |
| Dexpanthenol | The therapeutic efficacy of Dexpanthenol can be decreased when used in combination with Fluocortolone caproate. |
| Vitamin D | The therapeutic efficacy of Vitamin D can be decreased when used in combination with Fluocortolone caproate. |
| 1alpha-Hydroxyvitamin D5 | The therapeutic efficacy of 1alpha-Hydroxyvitamin D5 can be decreased when used in combination with Fluocortolone caproate. |
| Previtamin D(3) | The therapeutic efficacy of Previtamin D(3) can be decreased when used in combination with Fluocortolone caproate. |
| Diethylstilbestrol | The serum concentration of Fluocortolone caproate can be increased when it is combined with Diethylstilbestrol. |
| Etonogestrel | The serum concentration of Fluocortolone caproate can be increased when it is combined with Etonogestrel. |
| Desogestrel | The serum concentration of Fluocortolone caproate can be increased when it is combined with Desogestrel. |
| Megestrol acetate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Megestrol acetate. |
| Levonorgestrel | The serum concentration of Fluocortolone caproate can be increased when it is combined with Levonorgestrel. |
| Progesterone | The serum concentration of Fluocortolone caproate can be increased when it is combined with Progesterone. |
| Medroxyprogesterone acetate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Medroxyprogesterone acetate. |
| Norethisterone | The serum concentration of Fluocortolone caproate can be increased when it is combined with Norethisterone. |
| Estradiol | The serum concentration of Fluocortolone caproate can be increased when it is combined with Estradiol. |
| Ethynodiol diacetate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Ethynodiol diacetate. |
| Mifepristone | The serum concentration of Fluocortolone caproate can be increased when it is combined with Mifepristone. |
| Norgestimate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Norgestimate. |
| Ethinylestradiol | The serum concentration of Fluocortolone caproate can be increased when it is combined with Ethinylestradiol. |
| Mestranol | The serum concentration of Fluocortolone caproate can be increased when it is combined with Mestranol. |
| Drospirenone | The serum concentration of Fluocortolone caproate can be increased when it is combined with Drospirenone. |
| Estrone sulfate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Estrone sulfate. |
| Octylphenoxy polyethoxyethanol | The serum concentration of Fluocortolone caproate can be increased when it is combined with Octylphenoxy polyethoxyethanol. |
| Cyproterone acetate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Cyproterone acetate. |
| Trestolone | The serum concentration of Fluocortolone caproate can be increased when it is combined with Trestolone. |
| Norelgestromin | The serum concentration of Fluocortolone caproate can be increased when it is combined with Norelgestromin. |
| Gestodene | The serum concentration of Fluocortolone caproate can be increased when it is combined with Gestodene. |
| Hydroxyprogesterone caproate | The serum concentration of Fluocortolone caproate can be increased when it is combined with Hydroxyprogesterone caproate. |
| Ulipristal | The serum concentration of Fluocortolone caproate can be increased when it is combined with Ulipristal. |
| Dienogest | The serum concentration of Fluocortolone caproate can be increased when it is combined with Dienogest. |
| Norethynodrel | The serum concentration of Fluocortolone caproate can be increased when it is combined with Norethynodrel. |